91Ë¿¹ÏÊÓÆµ

Event

Homecoming: CWOQs Series 3: Class 3E "From the Bench to the Bedside"

Saturday, October 18, 2008 14:15to15:45
Arts Building 853 rue Sherbrooke Ouest, Montreal, QC, H3A 0G5, CA

Lectures are given by some of 91Ë¿¹ÏÊÓÆµâ€™s most eminent and engaging academics, and topics range from jazz appreciation to the latest developments in sustainable energy.

You may register for one class within each series. There is no charge for tickets. Admission is on a first-come, first-served basis.

The Mini-Med lecture series is one of 91Ë¿¹ÏÊÓÆµâ€™s most popular outreach programs. In this special Homecoming edition, Dean of Medicine and Vice-Principal, Health Affairs, Richard I. Levin will moderate a panel discussion featuring some of the University’s most distinguished cancer researchers. They will outline the critical discoveries taking place at 91Ë¿¹ÏÊÓÆµâ€™s new state-of-the-art Life Sciences Complex. From investigations in disease to pharmaceutical applications, 91Ë¿¹ÏÊÓÆµ is leading the way in translating research into better health and patient care.

The panel will feature Doctors Nicole Beauchemin, Gordon Shore and Michel L. Tremblay.

Nicole Beauchemin is a Professor in the Departments of Biochemistry, Medicine and Oncology and is on staff at the 91Ë¿¹ÏÊÓÆµ Cancer Centre. Her current research examines the relationship between obesity and the development of colon cancer.

Gordon Shore, PhD’74, is a Professor in the Departments of Biochemistry and Oncology at 91Ë¿¹ÏÊÓÆµ, as well as co-founder, director and chief scientific officer of Gemin X Pharmaceuticals, which specializes in the discovery and development of target-based novel cancer therapeutics.

Michel L. Tremblay is a James 91Ë¿¹ÏÊÓÆµ Professor and Director of the 91Ë¿¹ÏÊÓÆµ Cancer Centre. He also holds the Jeanne and J. Louis Lévesque Chair in Cancer Research at 91Ë¿¹ÏÊÓÆµ and was recently made a fellow of the Royal Society of Canada.

Please note is available until September 16, 2008. After this date, only phone, fax and mailed-in registrations will be processed.

Cost: Free

Back to top